Mirtazapine-induced manic switch in adolescent  unipolar depression.
Goyal
Nishant
N
Sinha
Vinod Kumar
VK
D000293:Adolescent; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000627:therapeutic use; D018692:Antimanic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D016651:Lithium Carbonate / Q000627:therapeutic use; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D011569:Psychiatric Status Rating Scales
D000929:Antidepressive Agents, Tricyclic; D018692:Antimanic Agents; D008803:Mianserin; D016651:Lithium Carbonate; D000078785:Mirtazapine